MedTrace Logo

Clinical Multimodal Surveillance of Respiratory Syndrome Pathogens

NCT07694648 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2398

Last updated 2026-07-10

No results posted yet for this study

Summary

This nationwide, multicenter observational study will establish and improve a hospital-based clinical surveillance and early warning system for respiratory syndrome pathogens. Clinical data and biospecimens generated during routine care will be collected from participating medical institutions every two weeks to monitor pathogen trends, support risk assessment, and provide evidence for prevention and control measures.

Conditions

  • Respiratory Tract Infections (RTI)
  • Respiratory Syndrome, Acute, Severe
  • Acute Respiratory Infections (ARIs)

Interventions

DIAGNOSTIC_TEST

Tiered pathogen testing and multi-omics analysis

Participants will undergo clinically indicated tiered testing, including SARS-CoV-2 nucleic acid testing, influenza A/B antigen or nucleic acid testing, routine blood testing, targeted sequencing or multiplex PCR, metagenomic next-generation sequencing, respiratory pathogen antibody testing, cytokine testing, and exploratory transcriptomics, metabolomics, proteomics, single-cell, microbiome, and related analyses using collected or clinically remaining samples.

Sponsors & Collaborators

  • Huashan Hospital

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-01
Primary Completion
2028-08-31
Completion
2028-09-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07694648 on ClinicalTrials.gov